What is the recommended Pap (Papanicolau) smear screening schedule for a 62-year-old female with no history of irregular results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a 62-year-old female with no history of irregular Pap smear results, routine cervical cancer screening with Pap tests should continue until age 65, after which she can discontinue screening if she has had adequate prior screening with normal results. Adequate prior screening is defined as three consecutive negative Pap tests or two consecutive negative HPV tests within the past 10 years, with the most recent test occurring within the past 5 years 1. The rationale for discontinuing screening at 65 is that cervical cancer develops slowly, and the risk of developing cervical cancer after this age is very low in women who have had regular normal screening 1. However, women with a history of high-grade precancerous lesions, cervical cancer, or certain risk factors like HIV infection should continue screening beyond age 65 1. It's essential to note that even after stopping cervical cancer screening, women should continue regular gynecological care and health maintenance visits 1. The American Cancer Society recommends that women aged 30-65 years should be screened every 5 years with the combination of HPV testing and cytology (“cotesting”) or every 3 years with cytology alone 1. Women who have had a total hysterectomy should stop cervical cancer screening if there is no history of high-grade squamous intraepithelial lesions, adenocarcinoma in situ, or cancer 1. The guidelines agree on most recommendations, including the recommended age at the start of screening (21 years), the age at which screening can be discontinued if the history of negative screening is adequate (>65 years), and the recommended interval between tests 1. Cotesting at a 5-year interval is either preferred or acceptable for women aged 30 to 65 years, whereas cytologic testing alone every 3 years is acceptable for women aged 21 to 65 years 1. The USPSTF Recommendation Statement also supports these guidelines, emphasizing the importance of regular screening for cervical cancer in women aged 21 to 65 years 1. In summary, the 62-year-old female should continue cervical cancer screening until age 65, after which she can discontinue screening if she has had adequate prior screening with normal results, and continue regular gynecological care and health maintenance visits 1.

From the Research

Pap Smear Screening Schedule

  • The recommended Pap smear screening schedule for a 62-year-old female with no history of irregular results is not explicitly stated in the provided studies.
  • However, according to the study 2, Pap tests are not currently recommended for women 65 years of age who participated adequately in screening programs.
  • This suggests that a 62-year-old female with no history of irregular results may not need to continue screening, but this decision should be made in consultation with a healthcare provider.
  • The study 3 found that most women prefer annual Pap smears and are resistant to the idea of less intense screening, but this study is older and may not reflect current guidelines or recommendations.
  • The study 4 estimates the age-specific rate and frequency of Pap screening in a U.S. health plan, but does not provide specific recommendations for a 62-year-old female.
  • The American College of Obstetricians and Gynecologists (ACOG) and the U.S. Preventive Services Task Force (USPSTF) provide guidelines for cervical cancer screening, but these guidelines are not explicitly cited in the provided studies.

Guidelines and Recommendations

  • The study 2 mentions that screening programs will be different in special populations at greatest risk, where tests are frequently needed or use of alternative methods.
  • The study 5 evaluates the impact of the current USPSTF recommendations for cervical cancer screening in young women, but does not provide recommendations for a 62-year-old female.
  • The study 6 discusses the importance of screening via Papanicolaou testing and interpretation of test results with knowledge of patient risk factors, but does not provide specific recommendations for a 62-year-old female.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Screening for cervical cancer: will women accept less?

The American journal of medicine, 2005

Research

Pap screening in a U.S. health plan.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.